News & Publications
News
Nov 4, 2026
Rebecca Abergel to present at Sixth REAC/TS International Symposium
Nov 1, 2026
HOPO Therapeutics enters Participant Basic Agreement with U.S. Army Contracting Command
May 29, 2026
HOPO Therapeutics joins the Medical Countermeasures Coalition
May 19, 2026
Morri Markowitz, MD joins HOPO Therapeutics as clinical advisor
Feb 4, 2026
Dan Hanfling, MD joins HOPO Therapeutics as advisor
Jan 13, 2026
Hannah Weber joins biodefense panel at DARPA and Ferocity Capital summit during J.P. Morgan Healthcare Conference
Publications
Proceedings of the National Academy of Sciences • Apr 2021
Genome-wide toxicogenomic study of the lanthanides sheds light on the selective toxicity mechanisms associated with critical materials
Roger M. Pallares, David Faulkner, Dahlia D. An, Solene Hebert, Alex Loguinov, Michael Proctor, Jonathan A. Villalobos, Kathleen A. Bjornstad, Chris J. Rosen, Christopher Vulpe, Rebecca J. Abergel
Nature • Feb 2021
Structural and spectroscopic characterization of an einsteinium complex
Korey P. Carter, Katherine M. Shield, Kurt F. Smith, Zachary R. Jones, Jennifer N. Wacker, Leticia Arnedo-Sanchez, Tracy M. Mattox, Liane M. Moreau, Karah E. Knope, Stosh A. Kozimor, Corwin H. Booth, Rebecca J. Abergel
Scientific Reports • Mar 2018
Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents
Julian A. Rees, Gauthier J.-P. Deblonde, Dahlia D. An, Camille Ansoborlo, Stacey S. Gauny, Rebecca J. Abergel
New Journal of Chemistry • Feb 2018
Toxic heavy metal – Pb, Cd, Sn – complexation by the octadentate hydroxypyridinonate ligand archetype 3,4,3-LI(1,2-HOPO)
Gauthier J.P. Deblonde, Trevor D. Lohrey, Dahlia D. An, Rebecca J. Abergel